longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Axe Compute

AGPU

12.60014.65% ( +1.610 )
Trading: Sep 17, 12:41:02 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -0.50, below the reasonable range, cheaper than 97.98% of the time in the past 1 years, and the industry ranks 70/175, the industry Median -0.88.

-0.503xP/E
$10.99Stock price
$-21.87Earnings per share
-0.503xP/E
Stock price$10.99Earnings per share$-21.87

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-0.17x
Typical range
-0.32x–-0.09x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
011223344

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
BAXUSBaxter
-11.44x141.71%$12.16B
GKOSUSGlaukos
-51.27x75.34%$9.64B
TFXUSTeleflex
-5.26x118.39%$5.42B
IRTCUSIRhythm
-264.28x71.96%$3.69B
PLSEUSPulse Biosciences
-44.20x27.55%$3.54B
AXGNUSAxogen
-79.47x31.25%$2.67B
BFLYUSButterfly Network
-25.83x34.41%$1.93B
ASSTUSStrive
-1.94x63.26%$1.90B
NVCRUSNovocure
-12.71x2.52%$1.89B
ATECUSAlphatec
-14.74x41.67%$1.62B
KMTSUSKestra Medical Tech
-9.42x0.94%$1.41B
DRTSUSAlpha Tau Medical
-15.00x--$1.39B
IARTUSIntegra LifeSciences
-172.59x109.50%$1.25B
AORTUSArtivion
-382.29x266.67%$1.22B
TNDMUSTandem Diabetes
-19.26x77.82%$1.22B
PRCTUSPROCEPT BioRobotics
-10.14x3.47%$1.11B
ENOVUSEnovis
-0.98x100.97%$1.08B
BBNXUSBeta Bionics
-13.67x16.08%$997.87M
CBLLUSCeribell
-14.25x35.15%$940.26M
SIBNUSSI-BONE
-56.79x8.85%$830.94M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.